Mirador Therapeutics: Over $400 Million Raised To Develop Precision Medicines For Immune-Mediated Diseases
By Amit Chowdhry ● Mar 25, 2024
Mirador Therapeutics - a company founded by Mark C. McKenna and led by several former executives of Prometheus Biosciences (acquired in 2023 by Merck for $10.8 billion) - launched this month. Mirador has raised over $400 million in financing led by ARCH Venture Partners, with early investments from OrbiMed and Fairmount. Other premier life sciences investors also joined, including Fidelity Management & Research Company, Point72, Farallon Capital Management, Boxer Capital, TCGX, Invus, Logos Capital, Moore Strategic Ventures, Blue Owl Healthcare Opportunities, Sanofi Ventures, Woodline Partners, Venrock Healthcare Capital Partners, RTW Investments and Alexandria Venture Investments.